A little-known fact when patients testify before the FDA:
Brown’s message about the need to reduce disproportionately high mortality rates among African-American women, like herself, resonated whether she was testifying before the FDA, addressing the nation’s mayors, or speaking with members of Congress, where she was a staff assistant to former US House Majority Leader Jim Wright.What few in Brown’s audiences knew is that the patient advocate personally profited from her cancer-survival message, accepting funding from major pharmaceutical companies that produce cancer treatments, according to tax records.
